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Abstract
Systemic sclerosis (SSc) or scleroderma is a chronic autoimmune disease characterized by vasculopathy, fibrosis, 
and autoimmunity. Scleroderma health assessment questionnare (SHAQ) is a measurement of SSc that is more 
specific than health assessment questionnaire (HAQ) disability index (DI) to measure disability and function.The 
aim of this study was to translate SHAQ into Indonesian language and assess its validity and reability. The SHAQ 
was translated into Indonesian language and then back translated to ensure the meaning. The Indonesian version 
was then applied to the SSc outpatients. The validity of HAQ-DI and VAS scores was assessed using Pearson Product 
Moment Correlation and Cronbach’s alpha for the reability test of SSc HAQ score. To determine the convergent 
validity, comparisons were made between HAQ-DI, scleroderma visual analog scale (VAS), and short form 36 (SF 
36). Eighteen females, ranging between 42 to 66 years old, were included in this study from Desember 2019 to 
February 2020. The results of the validity test in all variables of HAQ-DI and SSc-VAS were valid (r-count >0.361). 
Cronbach’s alpha for these variables were higher than the standardized items (r>0.700), reflecting very good 
reability and acceptable. There was a statistically significant correlation between SSc HAQ score and HAQ-DI with 
most of SF-36 physical domains, except for general health. The Indonesian version of SHAQ demonstrates a good 
construct and discriminant validity as well as the reproducibility. Thus, it can be used for measuring disability in 
systemic sclerosis patients. 
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Abstrak
Sklerosis sistemik atau skleroderma merupakan penyakit autoimun kronik dengan vaskulopati, fibrosis dan 
autoimunitas. Scleroderma health assessment questionnaire (SHAQ) menilai disabilitas dan fungsi pada pasien 
sklerosis sistemiklebih spesifik dibanding dengan health assessment questionnaire (HAQ) disability index (DI). 
Tujuan dari penelitian ini adalah menerjemahkan SHAQ ke dalam bahasa Indonesia dan menilai validitas serta 
relialibilitasnya. Scleroderma health assessment questionnaire diterjemahkan ke bahasa Indonesia dan kemudian 
dilakukan translasi balik, lalu kuesioner diisi oleh pasien sklerosis sistemik rawat jalan. Tes validitas HAQ-DI 
dan visual analog scale (VAS) dinilai dengan korelasi Pearson dan reliabilitas menggunakan Cronbach’s alpha. 
Perbandingan antara HAQ-DI, scleroderma-VAS dan short form 36 (SF 36) dilakukan untuk menilai validitas 
konvergen. Subjek terdiri dari 18 orang wanita yang berusia antara 42 sampai 66 tahun dari Desember 2019 
sampai Februari 2020. Hasil validitas pada semua parameter HAQ-DI dan SSc-VAS ditemukan valid (r hitung 
>0,361). Terdapat reliabilitas yang baik dilihat dari nilai Cronbach’s alpha yang lebih tinggi dari nilai r tabel 
(r>0,700). Terdapat korelasi yang signifikan antara skleroderma-HAQ dan HAQ-DI dengan domain SF-36 kecuali 
domain kesehatan umum. Simpulan, bahwa SHAQ versi Indonesia memiliki konsep dan validitas diskriminan 
serta reproduktifitas yang baik sehingga dapat digunakan untuk menilai disabilitas pada pasien sklerosis sistemik. 
Kata kunci: SHAQ, short form 36, sklerosis sistemik, VAS
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Introduction
Systemic sclerosis (SSc) is a chronic autoimmune 
disease that involves the connective tissues and 
multiorgan system. The SSc has three main 
characteristics, namely vasculopathy, fibrosis, 
and autoimmunity.1In a cross-sectional study, 
SSc is observed to have a significantly lower 
health-related quality of life (HRQoL) compared 
to the general population.2
Incidence of SSc ranges from 4 to 43 
individuals per million population annually, 
with a prevalence rate ranging from 70 to 340 
cases per million population,3 and affects female 
populations more than male with a proportion 
of 4:1. Symptoms of Raynaud’s phenomenon, 
skin thickening, and internal organ dysfunction 
are observed in these individuals with females 
experience Raynaud’s phenomenon more 
frequently than males with a ratio of about 
9:1.45 According to data obtained from dr. Hasan 
Sadikin General Hospital Bandung in 2017, 
SSc is the third most common disease in the 
Rheumatology Department with an increasing 
incidence from 189 patients per year in 2013 to 
196 patients per year in 2014.6
The health assessment questionnaire (HAQ) 
disability index (DI)is an assessment tool that 
was initially used to measure disability and 
function in rheumathoid arthritis. This index has 
been validated and used in several SSc studies.7 
The HAQ DI was considered to be not adequately 
specific for SSc measurement that Steen and 
Medsger8 then published the scleroderma health 
assessment questionnaire (SHAQ) in 1997.  The 
SHAQ itself consists of HAQ-DI (eight domains) 
with the addition of five analog visual scales (VAS) 
to assess digital ulcers, Raynaud’s phenomenon, 
gastrointestinal and lung symptoms, and overall 
diseases.
Systemic sclerosis treatment should 
include improving quality of life, hence it is 
necessary to assess disability and function 
using a reliable and valid measurement. SHAQ 
is a good measurement to do this. However, no 
Indonesian version of SHAQ has been adapted 
and validated to evaluate the SSc patients in 
Indonesia. The need for the Indonesian version 
is imminent because the SHAQ questionnaire 
can help to evaluate the improvement of the 
therapy and rehabilitation program provided 
to Indonesian SSc patients. This study aimed to 
make a standardized Indonesian version of SHAQ 
available by adapting it into Indonesian and test 
it for its validity, reliability, and its correlation 
with SF-36. 
Methods 
Eighteen female patients between the age of 
19 and 66 years were included in this study 
during the period of December 2019 to February 
2020. This study was approved by the Ethics 
Committee for Health Research of dr. Hasan 
Sadikin General Hospital Bandung, Indonesia, 
through the issuance of an ethical clearance 
number LB.02.01/X.6.5/142/2019. Informed 
consent was obtained from all subjects after a 
full explanation of the purpose and procedures 
used for the study was provided with a guarantee 
on anonymity and data confidentiality. All 
samples were taken according to the Declaration 
of Helsinki.9 Patients were recruited from the 
rheumatology outpatient clinic of dr. Hasan 
Sadikin General Hospital, Bandung, Indonesia.
Patients were included in the study if they fulfilled 
the preliminary classification criteria of SSc 
based on the American College of Rheumatology 
and European League Against Rheumatism 
(ACR/EULAR) in 201310 and were native 
Indonesian with good command and abstract 
thought to understand the concept of VAS. 
Patients with significant cognitive impairment 
were excluded. The objective of the study was 
explained to each of the patients before they fill 
out the questionnaires. After the participants 
gave consent, they were asked to fill in the self-
administered questionnaires that included the 
Indonesian versions of SHAQ and the SF-36. 
Authorization was obtained from the authors of 
SHAQ for its use in the present study. The HAQ-
DI, SHAQ VAS, and SF-36 were used in this study 
due to their ability in assessing the relationship 
between different SSc patients’ quality of life. 
HAQ-DI consists of 20 items which are divided 
into eight domains of dressing and grooming, 
arising, eating, walking, hygiene, reach, grip, 
and activities. The response to each item ranges 
from “without any difficulty (0)” to “with some 
difficulty (1)”, “with much difficulty (2)”, and 
“unable to do (3)”. For example, if the patient 
needs any device or help to do activities in any of 
the domains, he or she will automatically receive 
score 2. The highest scores in each domain are 
added and then divided by 8 to determine the 
HAQ-DI. The final score will range between 0 and 
3, with higher scores showing more disability.6
The SHAQ consists of HAQ-DI with five 
additional VAS questions: “in the past week, how 
much have your Raynaud’s phenomenon, digital 
ulcers, gastrointestinal and lung symptoms, and 
overall diseases interfered with your activity?” 
The answer is marked on a 15 cm long VAS line 
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starting from “does not interfere” to “very severe 
limitations”. The VAS score is multiplied by 0.2 
to obtain the final score. The score ranges from 
0 to 3, representing the minimum limitation 
to the maximum limitation8. George et al.11 has 
constructed a global score that is referred to as 
the “SSc HAQ score”, with a score ranging from 0 
to 3, which is a new measurement for pooling the 
five organ VAS into calculation. This new variable 
is calculated as follows: SSc HAQ score= (8 HAQ-
DI domains scores + 5 VAS scores) divided by 13.
Short Form 36 (SF-36) is a questionnaire 
consisting of 36 items that evaluate the quality of 
life in eight domains: physical functions, physical 
role, bodily pain, general health, vitality, social 
functions, emotional role, and mental health. 
Each domain is assessed by its specific score, 
which ranges from 0 to 100, with a higher score 
shows a better health status.12 Laras, Perwitasari, 
and Khoirunisa13 have already translated and 
validated the Indonesian version of SF-36 in 
autoimmune patients.
The initial English version of SHAQ was first 
translated into Indonesian by two translators, 
informed and uninformed about the objective of 
the questionnaire (T1, T2). Both of the translators 
and a physician who participated in the study 
compared and discussed the translation results 
until an agreed translation version was achieved 
(T12). Back translation was carried out by two 
different uninformed certified translators with 
non-clinical background into English, as the 
original language used for this questionnaire 
(BT1, BT2). The translations were then reviewed 
by the experts to reach a consensus on the final 
Indonesian version of SHAQ. Subsequently, 
all translated versions were compared and 
evaluated, and a final version was made.
The cognitive debriefing was performed on 
five patients with SSc using the final Indonesian 
version. There was a difficulty in understanding 
the term “Raynaud’s phenomenon” in four out 
of five patients. We added a description using 
brackets after the “Raynaud’s phenomenon” 
to explain the meaning of this item, which is 
“fingers that alternate in color between purple, 
paleness, and red, due to the cold”, according 
to the Brazilian Portuguese version of SHAQ.15 
Cognitive debriefing was carried out one more 
time on a new group of five patients with SSc 
and all patients were able to understand the 
questions. No major modification was needed 
for other items. 
The normality of the variables were analyzed 
using the Shapiro-Wilk test and were reported in 
mean±standard deviation (SD). Validity testing 
of HAQ-DI and VAS was performed by using data 
obtained from the results of the questionnaire. 
Pearson Product Moment Correlation was 
used for this purpose, with the questionnaire 
considered valid if the Pearson Product Moment 
correlation coefficient value was greater than the 
correlation coefficient value table.14 Reliability 
testing of SSc HAQ score was carried out using 
the Cronbach Alpha and the reliability was 
established if the coefficient value or r was ≥0.7. 
Convergent validity was carried out to assess the 
correlations between HAQ-DI, VAS, SSc HAQ, and 
SF-36 health scores in terms of quality of life. 
Moderate to high associations were expected 
between HAQ-DI and SSc HAQ score with the 





No occupation (housewives) 10 (55.6%)
With occupation 8 (44.4%)
Education level
Elementary school 0 (0%)
Junior high school  5 (27.8%)







VAS raynaud’s phenomenon 1.12±0.690
VAS finger ulcer 1.16±0.889










SHAQ= scleroderma health assessment questionnaire; 
HAQ= health assessment questionnaire; VAS= visual 
analogue scales; SF-36= short form 36
IR Defi, et al: Translation and Validation of Indonesian Version of Scleroderma Health Assessment Questionnaire 
Majalah Kedokteran Bandung, Volume 52 No. 1, March 202048
SF-36 physical items. For validity and reliability 
testing, the SPSS 13 software was used. 
Results
Eighteen SSc patients completed the final SHAQ-
DI and SF-36 questionnaires. The demographic 
characteristics and distribution of the sample 
are presented in Table 1. All subjects were 
female aged between 42 to 66 years old with the 
mean age (±SD) of 42.72±12.809. Most of them 
were housewives (55.6%) and had a diploma 
education (38.9%). At baseline, the mean (±SD) 
HAQ-DI score was 0.66±0.65, indicating the 
presence of mild to moderate disability among 
the SSc patients in this study.
To test the item validity, the Pearson Product 
Moment was used. The variable value correlation 
and the obtained total value were compared 
with the reference to the significant level table. 
The results of the validity testing in all variables 
Table 2 Validity Testing of HAQ Variables Using Pearson’s Correlation Coefficient
Variable Question Item 






1 0,731 0,361 Valid
2 0,765 0,361 Valid
Arising
1 0,746 0,361 Valid
2 0,784 0,361 Valid
Eating 
1 0,817 0,361 Valid
2 0,794 0,361 Valid
3 0,634 0,361 Valid
Walking
1 0,699 0,361 Valid
2 0,714 0,361 Valid
Hygiene
1 0,624 0,361 Valid
2 0,739 0,361 Valid
3 0,604 0,361 Valid
Reach
1 0,739 0,361 Valid
2 0,906 0,361 Valid
Grip
1 0,771 0,361 Valid
2 0,741 0,361 Valid
3 0,813 0,361 Valid
Activities 
1 0,819 0,361 Valid
2 0,813 0,361 Valid
3 0,680 0,361 Valid
Table 3 Validity Testing of VAS Variables Using Pearson’s Correlation Coefficient
Variable Total Item Correlation (r-count) Perception Rate Significant Level Conclusion 
VAS pain 0.734 0,361 Valid
VAS intestinal 0.540 0,361 Valid
VAS Breathing 0.585 0,361 Valid
VAS Raynaud’s 0.877 0,361 Valid
VAS finger ulcer 0.872 0,361 Valid
VAS overall disease severity 0.915 0,361 Valid
VAS=visual analogue scales
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of HAQ-DI showed that all variables were valid 
(r-count >0.361) (Table 2). The same was also 
true for all variables of VAS (Table 3). 
The reliability of SHAQ based on the use of 
the SSc HAQ score was presented in Table 4. The 
value of Cronbach’s alpha was higher than the 
standardized items (Cronbach’s alpha >0.700), 
meaning that the Indonesian version of the SHAQ 
questionnaire for SSc patients in this study was 
highly reliable and acceptable.
Convergent validity was assessed to see the 
correlation between HAQ DI, SSc HAQ score, SSc-
VAS domains, and SF-36 domains (Table 5). The 
HAQ-DI, SSc HAQ score, and SSc-VAS presented 
a correlation with the SF-36 component scores. 
There was a moderate negative correlation 
between the SF-36 physical functioning and 
HAQ-DI scores (r=-0.557) and SSc HAQ score 
(r=-0.557) with a moderate negative correlation 
between role limitation-physical and HAQ-
DI (r=-0.664), SSc HAQ score (r=-0.512) and 
VAS intestinal (r=-0.589). Moderate negative 
correlation were seen between the body pain 
and HAQ-DI (r=-0.694), SSc HAQ score (r=-
0.539), VAS pain (r=--0.478) and VAS Raynaud’s 
(r=-0.545) while a moderate negative correlation 
was observed between vitality and HAQ-DI (r=-
0.606), SSc HAQ score (r=-0.602) and overall 
disease severity VAS (r=-0.484). A moderate 
negative correlation was identified between role 
limitation-emotional with HAQ-DI (r=-0.677) 
and SSc HAQ score (r=-0.551) and a moderate 
Tabel 4 Reliability Testing of SSc HAQ Score 
Variable Cronbach’s Alpha
Cronbach’s 
Alpha Based on 
Standardized 
Items
n of Items Conclusion
SSc HAQ score 0.954 0.700 20 Reliable 
SSc HAQ score= (8 HAQ domains + 5 SSc VAS)/13 (Georges, 2005); HAQ= health assessment questionnaire; VAS= visual 
analogue scale 
Table 5  Convergent validity. Pearson and Spearman’s Correlation Coefficients Matrix Between 
   HAQ-DI, SSc HAQ Score, VAS and SF-36 Dimensions
























-0.664** S -0.512* -0.248 S -0.589** S 0.018 S -0.134 S 0.027 S -0.195 S
Body pain 
(BP) -0.694**
 S -0.639* -0.478** S -0.083 S 0.101 S -0.545** S -0.237 S -0.425 S
General 
health (GH) -0.357
 S -0.272 0.005 S -0.205 S -0.114P -0.196 P -0.115 P -0.115 P
Vitality (VT) -0.606** S -0.602** -0.280 S -0.139 S -0.175P -0.483 P -0.391 P -0.484** P
Social 
function (SF) -0.374





-0.677** S -0.551* -0.092 S -0.419 S -0.283 S -0.334 S -0.161 S -0.236 S
Mental health 
(MH) -0.168
 S -0.229 -0.006 S -0.036 S -0.274P -0.173 P -0.493** P -0.247 P
Note: *p<0.05; ** p<0.01; r= correlation coefisien; p= pearson; s= spearman ; SHAQ=scleroderma health assessment questionnaire; 
HAQ-DI= health assessment questionnaire disability index; VAS= visual analogue scales; SF-36= short form 36. SSc HAQ Score= (8 
HAQ domains + 5 SSc VAS)/13 (Georges, 2005) 
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negative correlation was seen between mental 
health and VAS finger ulcers (r=-0.493). All 
correlations were statistically significant at 0.01 
and 0.05 levels.
Discussion
The present study confirms the value of the 
SHAQ and demonstrates the psychometric 
properties in Indonesian SSc patients. The 
psychometric properties were indicated by 
the validity and reliability score as shown 
in Table 2, Table 3, and Table 4. These also 
show that Indonesian version of SHAQ has 
a good construct and discriminant validity. 
This study has a similar problem with 
regards to a cross-cultural adaptation as in 
the Brazilian Portuguese version of SHAQ,15 
which is the patients’ ability to understand the 
term “Raynaud’s phenomenon”. The Brazilian 
Portuguese adds a description after the 
“Raynaud’s phenomenon” to explain the meaning 
of this term, which is “fingers that alternate in 
color between purple, paleness and red, due to 
the cold”. With the same constraints, this study 
also add the same description as the previous 
study to explain the “Raynaud’s phenomenon” so 
subjects can understand this question. Just like 
the study conducted by Karadag et al.,16 these 
difficulties might be related to the demographics 
of the study population with the majority is 
unemployed women (housewives) with lower 
socio-cultural status.
All items in the Indonesian version of HAQ-
DI and SSc-VAS presented a significant result 
when tested for item validity to assess the 
feasibility of the items. To determine whether 
an item is feasible or not, it should be tested for 
the significance of the correlation coefficient 
test at 0.05 significance level, meaning that an 
item is considered feasible if it has a significant 
correlation to the total score.14
The invalid results of the validation test 
will affect the reliability test. However, if the 
validity does not exceed half of the contents of 
the dimension, this will not affect the overall 
reliability of the questionnaire.14 Georges et al.11 
proposed the use of combined score obtained by 
pooling the eight domains of the HAQ-DI and the 
five VAS scale, which is referred to as the “SSc HAQ 
score” to assess the multisystemic characteristics 
of SSc more accurately. The reliability test in 
this study used this SSc HAQ score. The results 
of the reliability show that, in general, the 
items in the Indonesian version of SHAQ are 
adequately reliable to be used on SSc patients. 
Quality of life was assessed using the SF-36 
questionnaire and, as expected, there was a 
statistically significant correlation between this 
SSc HAQ score and HAQ-DI with most of SF-36 
physical domains (FC, RP, DP), except for the 
general health (GH). In a cross-sectional study, it 
is identified that the main factors associated with 
the quality of life in SSc patients are functional 
disability and the anxiety.18
George et al.11 stated that there is an influence 
on the mood of the patients as an ultimate part 
of the appreciation of their disability in any 
native language people. Based on a systematic 
review, the prevalence of depressive symptoms 
among SSc patients in a study is 65%, where 
patients have depression symptoms that 
might be associated with joint pain and other 
symptoms and their duration and severity.19 
The pathogenesis of depression symptoms 
in autoimmune disease might result from the 
autonomic and immunological pathways and 
also changes in the cognitive, behavioral, and 
social status of the SSc patients.20
The limited number of subjects in this study 
might affect the convergent validity results, 
with just a few of VAS domains correlate with 
the physical domain of SF-36. Furthermore, 
many of the factors will influence pain and 
eventually affect the score of VAS domain, where 
physical impairment is often associated with 
reductions in both physical and mental health 
of patients with systemic scleroderm.17 There is 
no correlation between the social function with 
all domains of SF-36, which may be related to 
the demographic data of occupation because the 
majority of subjects in this study are housewives 
(unemployed) so the scope of socialization is 
reduced in non-working people.
There are just several significant correlations 
found between the VAS domains and SF-36 
domains in this present study. Orlandi et al.15 
stated that changes in VAS scores can be affected 
by changes in weather and can sufficiently change 
the symptoms of the disease, thus affecting the 
statistical results of SHAQ.
The preliminary results from this study 
demonstrated the potential value of SHAQ 
Indonesian version questionnaire for systemic 
scleroderma patients. This questionnaire can 
be used in an outpatient setting due to its ease 
and efficiency that enable the clinicians to apply 
them as a part of routine care in the evaluation of 
SSc patients.16 
The strength of this study is that the 
Indonesian version of SHAQ is the first study 
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that has been done in Indonesia and has been 
able to prove that this version is valid and 
reliable. The limitation of this study include 
the fact that the Indonesian version of SHAQ 
can only be applied to the general type of SSc, 
and has not included a detailed explanation 
of the subtype of SSc. Further study with the 
specific subtype of SSc is therefore needed. 
The Indonesian version of SHAQ demonstrated 
a good construct and discriminant validities, as 
well as good reproducibility. Thus, it can be used 
for measuring disability and function of systemic 
sclerosis patients in clinical practice or research. 
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